In Brief:
In our multicenter cluster-randomized, stepped-wedge clinical trial, targeting normoxemia did not increase supplemental oxygen-free days among adult patients with acute thermal burns admitted to a specialized burn unit, but safely reduced utilization of supplemental oxygen.
Go to Full Text of this Article